Aurobindo Pharma Ltd share price logo

Aurobindo Pharma Ltd

NSE: AUROPHARMA

BSE: 524804

Mid Cap

Healthcare Sector

Pharma Sector

₹1613.40

+27.50

(+1.73%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Financial Results & Merger Alert

Aurobindo Pharma reported 16.3% revenue growth, USFDA approval for 10 products, and approved merger of subsidiaries to simplify group structure.

Aurobindo Pharma Stock Performance

as on August 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,567.00
    ₹1,625.00
    downward going graph

    2.88%

    Downside

    0.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,016.10
    ₹1,636.80
    downward going graph

    37.02%

    Downside

    1.45%

    Upside

    downward going graph

Aurobindo Pharma share price movements today

Previous Close
₹1,585.90
Open
₹1,587.30
Volume
13.85L
Upper Circuit
₹1,662.80
Lower Circuit
₹1,566.00
Day's Low - High
₹1,567.00 - ₹1,625.00
52 Week Low - High
₹1,016.10 - ₹1,636.80

Aurobindo Pharma Historical Returns

1 Month Return
-0.55 %
3 Month Return
+ 11.05 %
1 Year Return
+ 46.94 %
3 Year Return
+ 82.65 %
5 Year Return
+ 74.64 %

Aurobindo Pharma Fundamentals

as on August 5, 2026 at 4:01 pm IST

Market Cap

₹92,109.33 Cr

Return on Equity (ROE)

8.68

PE Ratio (TTM)

26.28

Return on capital employed (ROCE)

10.82

Industry PE ratio

52.25

Beta (LTM)

0.41

P/B Ratio

3.28

Dividend Yield

0

PEG Ratio

49.59

Quarterly Earnings Growth YOY

1.99

EPS (TTM)

59.98

Book Value

562.21

Aurobindo Pharma Stock Valuation

as on August 5, 2026 at 4:01 pm IST

Aurobindo Pharma in the last 5 years

  • Overview

  • Trends

Lowest (6.73x)

March 23, 2020

Today (26.28x)

August 4, 2026

Industry (52.25x)

August 4, 2026

Highest (27.59x)

December 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 26.28x

Aurobindo Pharma Technical Analysis

Track how Aurobindo Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish3
Bullish8
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-0.13
Bullish
CCI (20)
37.99
Neutral
RSI (14)
49.54
Neutral
Momentum (10)
0
Neutral
ADI (14)
64.61
Neutral
Ultimate Oscillator (7,14,28)
94.06
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1614.44
Bullish
EMA (20)
1614.95
Bullish
VWMA (20)
1614.8
Bullish
SMA (50)
1616.32
Bearish
EMA (50)
1615.06
Bearish
SMA (200)
1612.69
Bullish
EMA (200)
1611.44
Bullish
KAMA (200)
1614.74
Bullish
DEMA (200)
1618.97
Bearish

Aurobindo Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aurobindo Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY92,109.3314.93%0.603,48331,723
Sanofi India Ltd image
Sanofi India Ltd
BUY7,817.07-12.29%0.004132,013
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,12,717.9318.66%0.695,02651,180
Abbott India Ltd image
Abbott India Ltd
BUY59,128.1311.05%0.001,4146,445
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY44,841.7811.84%0.561,0353,821
See all

Market expectation of Aurobindo Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

66.67%

Buy

18.52%

Hold

14.81%

Sell

Aurobindo Pharma Stock’s Investor Sentiment and Interest

Investment in Aurobindo Pharma Ltd Shares on INDmoney has dropped by -45.41% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-45.41% versus previous 30 day period

Search interest for Aurobindo Pharma Ltd Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-28% versus previous 30 day period

Aurobindo Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
7,150.71
7,271.23
7,491.92
7,457.65
7,646.21
7,893.15
8,381.12
7,791.77
8,236.96
8,604.51
8,751.5
Other Income
187.88
162.52
135.62
220.93
136.3
158.88
134.81
107.22
122.25
188.01
117.04
Total Income
7,407.3
7,514.3
7,715.77
7,787.95
7,932.37
8,137.4
8,516.93
7,975.36
8,407.95
8,833.91
8,970.38
Expenses
5,845.98
5,753.06
6,042.11
5,948.84
6,229.93
6,400.54
6,622.39
6,265.11
6,607.6
6,937.89
7,102.99
Operating Profit
1,304.73
1,518.17
1,449.81
1,508.81
1,416.28
1,492.61
1,758.73
1,526.66
1,629.36
1,666.62
1,648.51
Operating Profit Margin %
18.25%
20.88%
19.35%
20.23%
18.52%
18.91%
20.98%
19.59%
19.78%
19.37%
18.84%
Profit Before Interest, Tax and Depreciation
1,561.32
1,761.24
1,673.66
1,839.11
1,702.44
1,736.86
1,894.54
1,710.25
1,800.35
1,896.02
1,867.39
Interest
68.18
75.55
89.43
111.04
112.7
118.48
115.02
97.75
95.24
92.77
98.21
Depreciation
417.5
423.27
354.33
404.18
382.28
418.53
444.43
405.7
429.19
464.73
478.57
Profit Before Tax
1,075.64
1,262.42
1,229.9
1,323.89
1,207.46
1,199.85
1,335.09
1,206.8
1,275.92
1,338.52
1,290.61
Tax Paid
323.7
322.45
322.55
405.67
390.51
354.28
432.26
382.6
427.79
428.72
369.77
Profit After Tax
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
Total Net profit including share of profit / Loss from associate company
751.94
939.97
907.35
918.22
816.95
845.57
902.83
824.2
848.13
909.8
920.84
EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Actual EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Adjusted EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86
Diluted EPS
12.83
16.04
15.51
15.69
14
14.56
15.56
14.2
14.61
15.67
15.86

Aurobindo Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
16,232.87
19,225.92
22,737.95
24,557.95
23,366.55
24,617.13
28,704.5
31,378.13
33,384.74
Other Income
105.12
118.36
86.2
3,195.42
320.35
290.59
557.38
621.85
493.61
Total Income
16,604.96
19,681.91
23,184.7
27,970.05
23,775.84
25,145.97
29,559.25
32,345.58
34,146.69
Expenses
12,728.08
15,759.95
18,315.2
19,496.58
19,227.94
21,148.41
23,367.89
25,172.63
26,872.68
Operating Profit
3,504.79
3,465.97
4,422.75
5,061.37
4,138.61
3,468.72
5,336.61
6,205.5
6,512.06
Operating Profit Margin %
21.59%
18.03%
19.45%
20.61%
17.71%
14.09%
18.59%
19.78%
19.51%
Profit Before Interest, Tax and Depreciation
3,876.88
3,921.96
4,869.5
8,473.47
4,547.9
3,997.56
6,191.36
7,172.95
7,274.01
Interest
77.71
162.66
159.77
74.49
48.64
140.48
289.71
457.24
383.97
Depreciation
557.97
667.95
966.71
1,055.38
1,126.52
1,244.58
1,521.66
1,649.42
1,778.19
Profit Before Tax
3,241.2
3,091.35
3,743.02
7,343.6
3,372.74
2,612.5
4,379.99
5,066.29
5,111.85
Tax Paid
818.28
726.85
913.51
2,009.77
725.63
684.85
1,211.02
1,582.72
1,608.88
Profit After Tax
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
Total Net profit including share of profit / Loss from associate company
2,422.92
2,364.5
2,829.51
5,333.83
2,647.11
1,927.65
3,168.97
3,483.57
3,502.97
EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Actual EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Adjusted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34
Diluted EPS
41.36
40.36
48.32
91.04
45.19
32.9
54.16
59.81
60.34

Aurobindo Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,419.76
3,278.58
1,954.52
1,650.97
4,381.28
3,329.05
5,016.48
2,386.75
2,434.52
3,924.62
Cash Flow from Investing Activities
-1,445.51
-1,787.18
-1,926.76
-2,904.39
-1,562.86
596.57
-3,211.36
-3,971.4
-4,241.78
-1,866.04
Cash Flow from Financing Activities
365.44
-1,915.26
864.15
1,919.06
-1,947.18
-1,364.94
-2,969.27
1,814.41
800.42
119.78
Net Cash Flow
339.69
-423.86
891.91
665.64
871.24
2,560.68
-1,164.15
229.76
-1,006.84
2,178.36

Aurobindo Pharma Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
51.83%
51.83%
51.83%
51.8%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.88%
DII
17.94%
20.23%
23.28%
24.77%
25.13%
25.2%
26.23%
26.93%
27.6%
27.68%
25.87%
25.1%
FII
0%
0%
18.02%
16.73%
16.59%
16.29%
15.33%
14.37%
14.21%
13.94%
15.24%
16.38%
Public
7.42%
6.85%
6.87%
6.7%
6.46%
6.69%
6.61%
6.87%
6.38%
6.55%
7.08%
6.64%
Total Outstanding Shares
58,59,38,609
58,59,38,609
58,59,38,609
58,59,38,609
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
58,08,01,623
57,53,77,895
Total Shareholders
2,59,638
2,41,944
2,44,575
2,38,622
2,48,488
2,57,962
2,69,323
2,72,208
2,47,662
2,36,859
2,41,298
2,39,073

Mutual Funds that own Aurobindo Pharma Stock

Check out the Mutual Funds with significant holdings in Aurobindo Pharma.

Aurobindo Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Aurobindo Pharma.

  • Aurobindo Pharma Ltd Earnings Results

    Aurobindo Pharma Ltd’s net profit jumped 1.97% since last year same period to ₹921.26Cr in the Q4 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated 1.21% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Aurobindo Pharma Ltd Dividends August,2025

    In the quarter ending June 2025, Aurobindo Pharma Ltd has declared dividend of ₹4.00 per share on 04 Aug 2025 - translating a dividend yield of 0.25%.

    Read More about Dividends

Aurobindo Pharma News & Key Events

  • img

    Today's Timeline - 05 August

    10:06 AM

    -

    Aurobindo Pharma to announce Q1 FY27 results; analysts expect high single-digit revenue growth.

    09:13 PM

    -

    Aurobindo Pharma's June quarter results exceed expectations, driven by growth in Europe and the US.

    09:58 PM

    -

    Aurobindo Pharma's Q2FY26 sales up 4.05%, net profit rises 12.07%, stock gains 1.87%.

  • img

    Today's Timeline - 05 August

    10:02 PM

    -

    Aurobindo Pharma's board approves merger of Eugia subsidiaries to streamline operations.

    10:04 PM

    -

    Aurobindo Pharma reports 16.3% revenue growth to INR 9,150 crore, driven by US and Europe markets.

Indices Featuring Aurobindo Pharma Stock

Check stock indices that include Aurobindo Pharma.

BSE 200

₹11,515.76

36.49 (▲0.32%)

S&P BSE 250 LargeMidCap

₹10,970.77

37.61 (▲0.34%)

Nifty 500

₹23,735.55

45.40 (▲0.19%)

Nifty Midcap Sel

₹14,880.30

8.80 (▲0.06%)

S&P BSE MidCap Select

₹18,741.76

84.42 (▲0.45%)

Nifty 200

₹14,251.35

16.15 (▲0.11%)

Nifty Midcap 100

₹63,605.25

113.65 (▲0.18%)

BSE Healthcare

₹50,962.19

173.47 (▲0.34%)

Nifty MidSmallcap 400

₹21,556.75

85.15 (▲0.40%)

Nifty Midcap 50

₹18,218.45

2.60 (▲0.01%)

NIFTY PHARMA

₹26,563.55

-33.95 (▲0.13%)

Nifty Midcap 150

₹23,403.45

55.70 (▲0.24%)

Nifty LargeMidcap 250

₹16,977.95

28.40 (▲0.17%)

Nifty Healthcare

₹16,709.90

-36.80 (▲0.22%)

S&P BSE 150 MidCap

₹17,207.26

59.05 (▲0.34%)

BSE 500

₹37,074.66

141.19 (▲0.38%)

S&P BSE 400 MidSmallCap

₹12,861.31

59.76 (▲0.47%)

Insights on Aurobindo Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 15.24% to 16.38% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 824.75 Cr → 921.26 Cr (in ₹), with an average increase of 3.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AUROPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, AUROPHARMA stock has moved up by 34.2%

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 51.82% to 51.88% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 7.97K Cr → 8.97K Cr (in ₹), with an average increase of 3.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 145.2% return, outperforming this stock by 62.5%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.79% to 16.71% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.08% to 6.64% in Jun 2026 quarter

Aurobindo Pharma Stock Futures & Options Contracts

View the latest movement in Aurobindo Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Aurobindo Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 25 Aug ₹1600 Call
August 25, 2026
₹1600
₹64.7
19.05
41.73%
AUROPHARMA 25 Aug ₹1700 Call
August 25, 2026
₹1700
₹24.7
8
47.9%
AUROPHARMA 25 Aug ₹1620 Call
August 25, 2026
₹1620
₹54.5
17.1
45.72%
AUROPHARMA 25 Aug ₹1640 Call
August 25, 2026
₹1640
₹44.7
13.5
43.27%

Aurobindo Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
AUROPHARMA 25 Aug Fut
August 25, 2026
-
₹1624.9
36.38
2.29%
AUROPHARMA 29 Sep Fut
September 29, 2026
-
₹1632.8
35.46
2.22%
AUROPHARMA 27 Oct Fut
October 27, 2026
-
₹1633.4
32.97
2.06%

About Aurobindo Pharma Ltd

Aurobindo Pharma Ltd is an Indian multinational pharmaceutical company incorporated in 1986. Aurobindo Pharma operates in several lines of business including APIs, generics, biosimilars, advanced drugs, and consumer healthcare.

The company is well known for its top products such as antibiotics, anti-malarials, cardiovascular, and anti-diabetic drugs. Its popular brands include Aurolife, Aurocare, Aurochem, and Aurovit. Aurobindo Pharma is one of the largest manufacturers of generic drugs in India, with a presence in over 150 countries worldwide.

Revenue: ₹8,751.50Cr as on March 2026 (Q4 FY26)
Net Profit: ₹920.84Cr as on March 2026 (Q4 FY26)
Listing date: 19 Oct, 1995
Chairperson Name: K Ragunathan
OrganisationAurobindo Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Ragunathan
E-voting on sharesClick here to vote

FAQs

What is Aurobindo Pharma share price today?

Aurobindo Pharma share price today stands at ₹1613.4 as on at the close of the market. Aurobindo Pharma share today touched a day high of ₹1625 and a low of ₹1567.

What is the 52 week high and 52 week low range for Aurobindo Pharma share?

Aurobindo Pharma touched a 52 week high of ₹1636.8 and a 52 week low of ₹1016.1. Aurobindo Pharma share price today i.e. is closed at ₹1613.4, which is -1.43% down from its 52 week high and 58.78% up from its 52 week low.

What is Aurobindo Pharma's market capitalisation today?

Aurobindo Pharma market capitalisation is ₹92,109.33 Cr as on .

How to buy Aurobindo Pharma shares?

To buy Aurobindo Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AUROPHARMA or Aurobindo Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aurobindo Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aurobindo Pharma trading volume today?

Aurobindo Pharma trading volume is 13.85L as on . This means that 13.85L shares of Aurobindo Pharma were bought and sold on the stock market during today's trading session.